RECRUITING

Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This research trial studies germ-line mutations in blood and saliva samples from patients with cancer. Studying samples of blood and saliva from patients with cancer in the laboratory may help doctors learn more about how inherited genetic mutations can affect cancer predisposition (an inherited increase in the risk of developing cancer), their impact on treatment response, and their role in cancer development.

Official Title

An Investigation of the Role of Germ-Line Mutations in Cancer Predisposition, Tumor Biology, and Response to Treatment

Quick Facts

Study Start:2014-09-16
Study Completion:2026-09-16
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02280161

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Pathologically or clinical confirmed tissue diagnosis of a cancer
  2. * Ability to understand and the willingness to sign a written informed consent
  1. * Patients will be excluded if their cancer cannot be confirmed
  2. * Refusal to sign the informed consent

Contacts and Locations

Principal Investigator

Joanne Weidhaas
PRINCIPAL_INVESTIGATOR
Jonsson Comprehensive Cancer Center

Study Locations (Sites)

Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095
United States

Collaborators and Investigators

Sponsor: Jonsson Comprehensive Cancer Center

  • Joanne Weidhaas, PRINCIPAL_INVESTIGATOR, Jonsson Comprehensive Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2014-09-16
Study Completion Date2026-09-16

Study Record Updates

Study Start Date2014-09-16
Study Completion Date2026-09-16

Terms related to this study

Additional Relevant MeSH Terms

  • Malignant Neoplasm